Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma

M Ilamathi, S Santhosh, V Sivaramakrishnan1

  • 1Department of Bioinformatics, CTOR Lab, School of Chemical and Biotechnology, SASTRA University, Thirumalaisamudram, Thanjavur-613401, Tamilnadu, India. sivaramakrishnan@scbt.sastra.edu.

Abstract

Insights

Artesunate (ATS) shows potential as a hepatocellular carcinoma (HCC) therapeutic by inhibiting signal transducer and activator of transcription 3 (STAT-3) signaling. This small molecule effectively suppresses cancer cell growth and promotes apoptosis in vitro.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Aberrant signal transducer and activator of transcription 3 (STAT-3) signaling is implicated in hepatocellular carcinoma (HCC) development.
  • Targeting STAT-3 presents a promising therapeutic strategy for HCC suppression.

Purpose of the Study:

  • To identify a small molecule inhibitor that specifically targets STAT-3 for HCC suppression.
  • To evaluate sesquiterpene lactone (STL) candidates as potential STAT-3 inhibitors.

Main Methods:

  • Utilized a unified computational and experimental approach to analyze STL candidates.
  • Assessed Artesunate's (ATS) inhibitory effects on STAT-3 activity, dimerization, and downstream targets in vitro.
  • Investigated ATS's impact on STAT-3 DNA binding and its cytotoxicity against cancer cells.

Main Results:

  • Artesunate (ATS) identified as a potent STAT-3 inhibitor, comparable to S3I-201.
  • ATS inhibited IL-6 driven STAT-3-DNA binding and STAT-3 dimerization in vitro.
  • ATS modulated STAT-3 dependent pro-apoptotic targets and exhibited selective cytotoxicity towards HCC cells.

Conclusions:

  • The study suggests ATS has potential as a therapeutic agent against HCC.
  • ATS demonstrates efficacy through STAT-3 inhibition, promoting apoptosis and selective cancer cell cytotoxicity.
  • Combined computational and in vitro data support ATS's role in HCC therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K